Big Pharma - Topic profile

Rubin needs to make money from his options. IMO

$$$$$$$$$$$

The FDA is now debating whether or not new and existing drugs should go through further testing to determine cardio risks. Pegloticase-based on 12 mo treatment data- has shown no adverse links to cardiovascular disease. In fact, recent large studies have shown that gout is the 3rd biggest risk factor to heart attacks. Lowering uric acid levels rapidly and eliminating gout may greatly ...

http://www.naturalnews.com/z023476.html (NaturalNews) It is the position of Big Pharma that pharmaceuticals make people healthier. That's the whole point of taking them, of course -- to enhance your health in some way that the human body apparently cannot achieve on its own (if you believe the drug ads, anyway). The drug industry's direct-to-consumer advertisements further imply this ...

This sums up some of my research. Dr. Blaylock, quoted in post, is one of the top neurosurgeons in the country. Russert's untimely death raises questions about how we're treating heart disease You won't hear me say this often about anyone in mainstream media, but Tim Russert, NBC newsman and anchor of Meet the Press, was someone I respected. I took great joy in ...

LONGS GET PHARMA'S SHORT MONEY.

As Medicare stakeholders frantically lobby to get their reforms included in physician payment relief legislation, an equally heated, but less urgent, debate is percolating on the FDA front involving biogenerics. While it is highly unlikely Congress will pass a biogenerics bill this year, the prospect of an Obama presidency has big Pharma nervous an aggressive biogenerics bill may be in the...

Yes, Dr. S talked about negotiations going well with a major pharmaceutical manufacturer. When asked who it was, he said that it wasn't a good idea to reveal the name. But, he did say they have been involved in this area before in a real off handed way. Personally, I think all arrows point to Baxter. He has worked with them before and we fall right in the range of their specialties. So, I ...

  Recs: 3 Article re: big pharma's need for pipeline Nothing to aquire? Still no interest in NBIX? Troubling. A weak economy and volatile stock market usually send investors fleeing to safe havens, where the profits are steady and the share prices don't hop around too much. Drug stocks used to fill that role, but not this year. Most Big Pharma stocks are getting ...

Good article, should have played well for ADLS, but who knows what the Flavins are doing to miss this opportunity? http://biz.yahoo.com/ibd/080613/general0... "The top risk involves lost sales of key products. In coming years, U.S. drug makers will lose patent protection on numerous blockbusters, including Pfizer's Lipitor cholesterol fighter, Merck's Singulair asthma ...

Thanks Doc -- Silly me, I let GOOG steer me to the Cleveland Clinic website and didn't see anything connecting MI & gout. aa

...according to key stats...book value is almost a negative two dollars. Heading that direction.

How very droll my friend. EDIT::: And this is what I found interesting:

Also fearing the Hemp family: Big Chemical Big Agra: Corn especially Big Timber Big Fossil Fuel any others folks................?